Rejuvenate Bio is a biotechnology startup founded in 2017, aiming to combat chronic age-related diseases. The company's focus is on leveraging gene expression and epigenetic reprogramming to reverse pre-existing conditions such as heart disease, metabolic disease, and kidney failure in humans. With its slogan "Targeting the core drivers of chronic age-related diseases to reverse pre-existing conditions in humans," Rejuvenate Bio has garnered attention in the health care industry. In April 27, 2021, the company secured a significant $14.58M in a Venture Round investment. Despite the absence of specific headquarters information, the recent investment highlights investor confidence in the potential of Rejuvenate Bio's innovative approach. This substantial funding could signify a pivotal point for the company's trajectory, as it continues to make strides in transforming the landscape of age-related disease treatment.
General Information
Get notified when Rejuvenate Bio moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Rejuvenate Bio
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About Rejuvenate Bio
Taxonomy: age-related diseases, gene expression, epigenetic reprogramming, chronic diseases, reversing pre-existing conditions, heart disease, metabolic disease, kidney failure, gene therapy, medical research, anti-aging, precision medicine
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | •••••• | 1 | •••• •••• | 01 Jul 2024 |
| Series A | •••••• | 5 |
|
12 Apr 2021 |
| Seed Round | •••••• | 3 |
|
01 Jun 2018 |
Rejuvenate Bio Alternatives & Competitors
Creating RNA-targeting gene therapies to treat devastating diseases
Leveraging genetics to treat neurological diseases
Toward the next generation of gene therapy.
FAQ About Rejuvenate Bio
Don't just browse. Track.
Signal Tracker monitors Rejuvenate Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.